Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2008-5434
2. Registrant Information.
Registrant Reference Number: 1947167
Registrant Name (Full Legal Name no abbreviations): Sure-Gro Inc.
Address: 150 Savannah Oaks Dr.
City: Brantford
Prov / State: Ontario
Country: Canada
Postal Code: N3V 1E7
3. Select the appropriate subform(s) for the incident.
Human
4. Date registrant was first informed of the incident.
11-JUN-08
5. Location of incident.
Country: CANADA
Prov / State: BRITISH COLUMBIA
6. Date incident was first observed.
12-MAY-08
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 27068
PMRA Submission No.
EPA Registration No.
Product Name: Later's Bugban-C Ant Killer Dust
7. b) Type of formulation.
Application Information
8. Product was applied?
Yes
9. Application Rate.
Unknown
10. Site pesticide was applied to (select all that apply).
Site: Res. - Out Home / Rés - à l'ext.maison
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
unknown
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform II: Human Incident Report (A separate form for each person affected)
1. Source of Report.
Medical Professional
2. Demographic information of data subject
Sex: Male
Age: >19 <=64 yrs / >19 <=64 ans
3. List all symptoms, using the selections below.
System
- Nervous and Muscular Systems
- Gastrointestinal System
- Symptom - Salivating excessively
- General
- Symptom - Lightheadedness
4. How long did the symptoms last?
Unknown / Inconnu
5. Was medical treatment provided? Provide details in question 13.
Yes
6. a) Was the person hospitalized?
Unknown
6. b) For how long?
7. Exposure scenario
Non-occupational
8. How did exposure occur? (Select all that apply)
Drift from the application site
9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)
Unknown
10. Route(s) of exposure.
Respiratory
11. What was the length of exposure?
Unknown / Inconnu
12. Time between exposure and onset of symptoms.
>2 hrs <=8 hrs / > 2 h < = 8 h
13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)
Telephone call came in from a medical doctor at the (name) Hospital regarding patient whom was using 5 % Later's Bugban- C ant killer dust. The wind shifted, and patient inhaled some of the dust, concerned about the active ingredient carbaryl and requested kg/toxic dose, inhalation was brief time of exposure 3hrs ago. Patient general healthy, history of bipolar, medications unknown (didn't have the names on hand). no known allergies. The patient is displaying symptoms of anxiousness, hyper salivation and light-headedness. The operator who fielded the call advised the Doctor that inhalation exposure that the symptoms displayed are unknown if related per the MSDS for the Laters Bugban-C Ant Killer Dust product. The active ingredient Carbaryl which is a reversible cholinesterase inhibitor. The antidote is atropine sulphate. Recommendations were to decontaminate patient with fresh air, wash off contaminated skin w/ soap and water and to give atropine if cholinergic symptoms occur. Outcome unknown as follow up call was made and the Medical Doctor who made the initial phone wasn't in and the patient name was unknown.
To be determined by Registrant
14. Severity classification.
Minor
15. Provide supplemental information here.